Treatment

GY

PFPN

GYIOC

AEN

GYV

GRIOC

NR

VCR

MR

Variety

2009 EVDT

1672

18.7

1375

14.7

50,000,000

40,000,000

20,000,000

2.31

1.31

IWDC2

2003

25.3

1619

20.1

60,000,000

50,000,000

30,000,000

3.02

2.02

DMR-ESR-Y

1432

17.2

1038

11.9

40,000,000

30,000,000

10,000,000

1.85

0.85

N-rates

b1

1238

41.3

881

29.4

40,000,000

20,000,000

10,000,000

1.79

0.79

b2

1301

21.7

944

15.7

40,000,000

30,000,000

10,000,000

1.8

0.81

b3

1687

18.7

1331

14.8

50,000,000

40,000,000

20,000,000

2.47

1.45

b4

1947

16.2

1584

13.2

60,000,000

40,000,000

30,000,000

2.83

1.83

b5

1943

13

1587

10.6

60,000,000

40,000,000

30,000,000

2.67

1.67

b6

2098

11.6

1736

9.7

60,000,000

50,000,000

30,000,000

2.81

1.8

LSDa

181.7

5.91

973.4

3.35

7,657,896

11,459,941

5,706,393

0.12

0.7

LSDb

154.7

2.6

256.2

0.95

7,234,275

6,521,884

5,856,943

0.21

0.2

LSDa*b

218.3

4.88

742.9

2.56

9,499,687

9549276.9

7,091,584

0.29

0.72

CV (%)

2.1

2.2

6.1

5

2.8

11.2

1.7

7

14.2